LOCATION OF LEWY BODIES IS DRIVING DOPAMINERGIC CELL VULNERABILITY IN NON-HUMAN PRIMATES

LOCATION OF LEWY BODIES IS DRIVING DOPAMINERGIC CELL VULNERABILITY IN NON-HUMAN PRIMATES

Bibliographic Details
Main Authors:	Julia Chocarro, Alberto Rico, Goiaz Ariznabarreta, Elvira Roda, Adriana Honrubia, Alfonso Vazquez, Patricia Arnaiz, Almudena Corcho, Sergio Maraña, Adriana Leon Villares, Jose Lanciego
Format:	Article
Language:	English
Published:	Elsevier 2023-10-01
Series:	IBRO Neuroscience Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2667242123007923

Similar Items

Development and characterization of a non-human primate model of disseminated synucleinopathy
by: Alberto J. Rico, et al.
Published: (2024-03-01)

Adeno-Associated Viral Vectors as Versatile Tools for Neurological Disorders: Focus on Delivery Routes and Therapeutic Perspectives
by: Ana Fajardo-Serrano, et al.
Published: (2022-03-01)

Adeno-Associated Viral Vectors as Versatile Tools for Parkinson’s Research, Both for Disease Modeling Purposes and for Therapeutic Uses
by: Ana Fajardo-Serrano, et al.
Published: (2021-06-01)

CALBINDIN CONTENT AND DIFFERENTIAL VULNERABILITY OF MIDBRAIN EFFERENT DOPAMINERGIC NEURONS IN MACAQUES
by: Iria G Dopeso-Reyes, et al.
Published: (2014-12-01)

AT1 RECEPTOR AUTOANTIBODIES MEDIATE EFFECTS OF METABOLIC SYNDROME ON DOPAMINERGIC VULNERABILITY.
by: Ana Isabel Rodríguez Pérez, et al.
Published: (2023-10-01)

Glucocerebrosidase Gene Therapy Induces Alpha-Synuclein Clearance and Neuroprotection of Midbrain Dopaminergic Neurons in Mice and Macaques
by: Diego Sucunza, et al.
Published: (2021-05-01)

Dopamine transporter glycosylation correlates with the vulnerability of midbrain dopaminergic cells in Parkinson's disease
by: Domingo Afonso-Oramas, et al.
Published: (2009-12-01)

MOLECULAR HETEROGENEITY OF NON-HUMAN PRIMATE MIDBRAIN DOPAMINERGIC NEURONS.
by: Nagore Hernández Pinedo, et al.
Published: (2023-10-01)

Vulnerability of mesostriatal dopaminergic neurons in Parkinson’s disease
by: Tomás González-Hernández, et al.
Published: (2010-10-01)

Influence of cell preparation and target location on the behavioral recovery after striatal transplantation of fetal dopaminergic neurons in a primate model of Parkinson’s disease
by: D.E. Redmond, Jr., et al.
Published: (2008-01-01)

PARKINSON’S DISEASE: ANIMAL MODELS AND DOPAMINERGIC CELL VULNERABILITY
by: Javier eBlesa, et al.
Published: (2014-12-01)

Brain renin-angiotensin system and dopaminergic cell vulnerability
by: Jose L Labandeira-Garcia, et al.
Published: (2014-07-01)

Visualizing advances in the future of primate neuroscience research
by: Peter Janssen, et al.
Published: (2023-01-01)

Molecular determinants of selective dopaminergic vulnerability in Parkinson’s disease: an update
by: Lars eBrichta, et al.
Published: (2014-12-01)

Selective dopaminergic vulnerability in Parkinson’s disease: new insights into the role of DAT
by: Maged M. Harraz, et al.
Published: (2023-08-01)

Developmental pathways linked to the vulnerability of adult midbrain dopaminergic neurons to neurodegeneration
by: Nilima Prakash
Published: (2022-12-01)

Dopaminergic cell damage and vulnerability to MPTP in Pink1 knockdown zebrafish
by: Ville Sallinen, et al.
Published: (2010-10-01)

Lewy Body-like Pathology and Loss of Dopaminergic Neurons in Midbrain Organoids Derived from Familial Parkinson’s Disease Patient
by: Andrea Becerra-Calixto, et al.
Published: (2023-02-01)

Cortical Lewy body injections induce long-distance pathogenic alterations in the non-human primate brain
by: Margaux Teil, et al.
Published: (2023-09-01)

Standards for Deriving Nonhuman Primate-Induced Pluripotent Stem Cells, Neural Stem Cells and Dopaminergic Lineage
by: Guang Yang, et al.
Published: (2018-09-01)

Removal verbs and locative alternations in Spanish
by: José Luis Cifuentes Honrubia
Published: (2008-12-01)

GUCY2C signaling limits dopaminergic neuron vulnerability to toxic insults
by: Lara Cheslow, et al.
Published: (2024-04-01)

Vulnerable combinations of functional dopaminergic polymorphisms to late-onset treatment resistant schizophrenia.
by: Kengo Oishi, et al.
Published: (2018-01-01)

Dendritic involvement in inhibition and disinhibition of vulnerable dopaminergic neurons in healthy and pathological conditions
by: R.C. Evans
Published: (2022-10-01)

In vivo human molecular neuroimaging of dopaminergic vulnerability along the Alzheimer’s disease phases
by: Arianna Sala, et al.
Published: (2021-11-01)

Transmission Mechanism of Lewy Body-Like α-Synucleinopathies in Dopaminergic Neurons Derived from Human Induced Pluripotent Stem Cells
by: Cheng Lin
Published: (2018-04-01)

Parkinson's disease: Cell Vulnerability and Disease Progression
by: Javier eBlesa, et al.
Published: (2015-09-01)

Metabolic Energy Capacity of Dopaminergic Grafts and the Implanted Striatum in Parkinsonian Nonhuman Primates as Visualized with Cytochrome Oxidase Histochemistry
by: Timothy J. Collier, et al.
Published: (1997-03-01)

Fischer 344 and Lewis rat strains as a model of genetic vulnerability to drug addiction
by: Cristina eCadoni
Published: (2016-02-01)

Neuromodulation of Prefrontal Cortex in Non-Human Primates by Dopaminergic Receptors during Rule-Guided Flexible Behavior and Cognitive Control
by: Susheel Vijayraghavan, et al.
Published: (2017-12-01)

Maybury-Lewis por Maybury-Lewis
Published: (2002-01-01)

Behavioral Correlates of Primates Conservation Status: Intrinsic Vulnerability to Anthropogenic Threats.
by: Amélie Christelle Lootvoet, et al.
Published: (2015-01-01)

Early Attachment Disruption, Inflammation, and Vulnerability for Depression in Rodent and Primate Models
by: Michael B. Hennessy, et al.
Published: (2019-01-01)

The Convergence of Alpha-Synuclein, Mitochondrial, and Lysosomal Pathways in Vulnerability of Midbrain Dopaminergic Neurons in Parkinson’s Disease
by: Georgia Minakaki, et al.
Published: (2020-12-01)

Neonatal exposure to lipopolysaccharide enhances vulnerability of nigrostriatal dopaminergic neurons to rotenone neurotoxicity in later life
by: Lir-Wan Fan, et al.
Published: (2011-12-01)

Chromosome 22q11.2 deletion causes PERK-dependent vulnerability in dopaminergic neurons
by: Yuko Arioka, et al.
Published: (2021-01-01)

Creativity in Higher Education: Comparative Genetic Analyses on the Dopaminergic System in Relation to Creativity, Addiction, Schizophrenia in Humans and Non-Human Primates
by: Bernard Wallner, et al.
Published: (2017-12-01)

PET 6-[<sup>18</sup>F]fluoro-L-m-tyrosine studies of dopaminergic function in human and nonhuman primates
by: Jamie L Eberling, et al.
Published: (2008-03-01)

Lewy body disease or diseases with Lewy bodies?
by: Kateřina Menšíková, et al.
Published: (2022-01-01)

Dose and location-dependent effects of transcranial magnetic stimulation in nonhuman primates
by: Nipun Perera, et al.
Published: (2023-01-01)